A 3-session online tool aims to calm caregivers' fear as cancer advances

NCT ID NCT07752992

First seen Aug 07, 2026 ยท Last updated Aug 07, 2026

Summary

This study tests a short, three-session online program designed to help caregivers of people with advanced prostate cancer manage their fear that the cancer will progress. The program teaches techniques like detached mindfulness to help caregivers relate to worrying thoughts in a new way. Researchers are checking whether the program is practical and acceptable to caregivers, and whether it may reduce their fear and anxiety.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Conquer Fear Carer Brief, a three-session online psychological intervention using detached mindfulness and attention training techniques
What this could lead to
If successful, this brief online program could offer a practical way to help caregivers manage the intense fear that a loved one's cancer may progress, improving their emotional well-being.
What could go wrong
This is a small feasibility study with only 14 participants, so results may not apply broadly. The intervention is brief and may not be enough for everyone, and some participants might not find it helpful or could experience temporary discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEAR OF CANCER PROGRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Psychology and Behavioural Sciences, Aarhus University

    RECRUITING

    Aarhus, 8000, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.